Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-30 Sale |
2023-10-31 4:09 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
21,573 | $12.02 | $259,256 | 40,927 (Direct) |
View |
| 2023-10-02 Sale |
2023-10-04 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
2,942 | $12.68 | $37,305 | 84,744 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks |
1,238 | $14.4 | $17,829 | 43,812 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
1,655 | $14.4 | $23,835 | 87,686 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
1,655 | $14.4 | $23,835 | 57,140 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
1,238 | $14.4 | $17,829 | 58,413 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
1,655 | $14.4 | $23,835 | 378,613 (Indirect Direct) |
View |
| 2023-06-08 Purchase |
2023-06-12 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director |
10,000 | $13.88 | $138,828 | 10,000 (Direct) |
View |
| 2023-05-10 Purchase |
2023-05-12 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director |
11,000 | $13.86 | $152,416 | 11,000 (Direct) |
View |
| 2023-03-21 Sale |
2023-03-23 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
7,500 | $15.57 | $116,782 | 0 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 4:14 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks |
1,159 | $15.1 | $17,500 | 89,650 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 4:12 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
1,159 | $15.1 | $17,500 | 102,981 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 4:09 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
1,370 | $15.1 | $20,686 | 124,695 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 4:07 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
971 | $15.1 | $14,661 | 154,045 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 4:04 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
1,370 | $15.1 | $20,686 | 446,168 (Indirect Direct) |
View |
| 2023-02-14 Sale |
2023-02-16 4:18 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
30,045 | $16 | $480,720 | 257,500 (Direct) |
View |
| 2023-01-24 Purchase |
2023-01-24 6:20 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner |
1,666,666 | $18 | $29,999,988 | 19,718,014 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 4:06 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
2,403 | $21.24 | $51,043 | 365,150 (Indirect Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 4:06 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks |
1,603 | $21.24 | $34,050 | 35,058 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
2,403 | $21.24 | $51,043 | 72,628 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
1,603 | $21.24 | $34,050 | 48,389 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
2,403 | $21.24 | $51,043 | 43,677 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
2,587 | $18.73 | $48,455 | 74,297 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-10-28 Option Award |
2023-10-31 4:09 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
62,500 | $0 | 40,927 (Direct) |
View |
| 2023-09-15 Option Award |
2023-09-19 4:05 pm |
N/A 2033-09-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Dhanak Dashyant EVP & Chief Scientific Officer |
140,900 | $0 | 206,800 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:05 pm |
N/A 2033-06-20 |
Deciphera Pharmaceuticals Inc. | DCPH | Martin John Richard Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:05 pm |
N/A 2033-06-20 |
Deciphera Pharmaceuticals Inc. | DCPH | Benz Edward J. JR Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:05 pm |
N/A 2033-06-20 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:05 pm |
N/A 2033-06-20 |
Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:05 pm |
N/A 2033-06-20 |
Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:05 pm |
N/A 2033-06-20 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelley Susan L. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:05 pm |
N/A 2033-06-20 |
Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:05 pm |
N/A 2033-06-20 |
Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-01 4:15 pm |
2022-04-28 N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner |
2,427,693 | $0 | 23,107,844 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-01 4:15 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner |
2,427,693 | $0.01 | 23,107,844 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:14 pm |
N/A 2033-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks |
55,751 | $0 | 89,650 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:12 pm |
N/A 2033-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
55,751 | $0 | 102,981 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:09 pm |
N/A 2033-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
82,388 | $0 | 124,695 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:07 pm |
N/A 2033-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
82,388 | $0 | 154,045 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:04 pm |
N/A 2033-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
82,388 | $0 | 446,168 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-16 4:18 pm |
N/A 2033-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
250,000 | $0 | 257,500 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 4:06 pm |
N/A 2033-01-16 |
Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director |
3,269 | $15.3 | 3,269 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 4:05 pm |
N/A 2033-01-16 |
Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director |
3,269 | $15.3 | 3,269 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 4:05 pm |
N/A 2033-01-16 |
Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director |
3,269 | $15.3 | 3,269 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 4:05 pm |
N/A 2033-01-16 |
Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director |
3,269 | $15.3 | 3,269 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 4:05 pm |
N/A 2033-01-16 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelley Susan L. Director |
3,269 | $15.3 | 3,269 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 4:05 pm |
N/A 2032-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director |
18,500 | $0 | 18,500 (Direct) |
View |